Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (23)

2023

  1. 30-day readmissions for circulatory system diseases in patients over 75 years with heart failure in Spain (2016-2018)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 8, pp. 655-656

  2. Age and stabilization of admissions for heart failure in Spain (2006-2019). The beginning of the end of the “epidemic”?

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 272-274

  3. Characteristics and in-hospital mortality of elderly patients with heart failure in Spanish hospitals

    Journal of Geriatric Cardiology, Vol. 20, Núm. 4, pp. 247-255

  4. Clinical features and outcomes of acute heart failure in nonagenarians: Results of a nationwide study

    Geriatrics and Gerontology International

  5. Diagnosis and Management of Malnutrition in Patients with Heart Failure

    Journal of Clinical Medicine, Vol. 12, Núm. 9

  6. Do Women Physicians Accept and Follow Heart Failure Guidelines More Than Men?

    Current Heart Failure Reports, Vol. 20, Núm. 3, pp. 151-156

  7. Ferric carboxymaltose for patients with heart failure in all-range ejection fraction

    REC: CardioClinics, Vol. 58, Núm. 4, pp. 281-288

  8. Gut Microbiota and Derived Short-Chain Fatty Acids Are Linked to Evolution of Heart Failure Patients

    International journal of molecular sciences, Vol. 24, Núm. 18

  9. One-year readmissions for circulatory diseases and in-hospital mortality after an index episode of heart failure in elderly patients. A nationwide data from public hospitals in Spain between 2016 and 2018

    Clinical Research in Cardiology, Vol. 112, Núm. 8, pp. 1119-1128

  10. Opinion on the 2021 ESC guidelines on heart failure: a cross-sectional survey of 387 doctors

    REC: CardioClinics, Vol. 58, Núm. 1, pp. 7-15

2022

  1. Frailty and prognosis of older patients with chronic heart failure

    Revista Espanola de Cardiologia, Vol. 75, Núm. 12, pp. 1011-1019

  2. Impact of blood pressure on management and prognosis of patients treated with sacubitril/valsartan

    REC: CardioClinics, Vol. 57, Núm. 2, pp. 116-122

  3. Sex differences in the impact of frailty in elderly outpatients with heart failure

    Frontiers in Cardiovascular Medicine, Vol. 9

2021

  1. Initiation and titration of sacubitril/valsartan in different types of centers

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 92-97

  2. Predictors of clinical improvement in heart failure patients with iron deficiency treated with ferric carboxymaltose

    REC: CardioClinics, Vol. 56, Núm. 4, pp. 250-257

2020

  1. Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan

    Cardiology (Switzerland), Vol. 145, Núm. 5, pp. 275-282

  2. Sacubitril/Valsartan is useful and safe in elderly people with heart failure and reduced ejection fraction. Data from a real-word cohort

    Revista Espanola de Geriatria y Gerontologia, Vol. 55, Núm. 2, pp. 65-69

2019

  1. Impaired blood glucose levels in patients with dyslipidemia: What are the therapeutic implications? the PREVENDIAB study

    Future Cardiology, Vol. 15, Núm. 3, pp. 175-182

  2. In-hospital Mortality and Readmissions for Heart Failure in Spain. A Study of Index Episodes and 30-day and 1-year Cardiac Readmissions

    Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 998-1004

  3. Sacubitril/Valsartan in Daily Clinical Practice: Data from a Prospective Registry

    Journal of Cardiovascular Pharmacology, Vol. 73, Núm. 2, pp. 118-124